Skip to main content

Kaufman Rossin Wealth, LLC

SEC CIK
0002049750
Latest filing
Jul 16, 2026

The latest 13F from Kaufman Rossin Wealth, LLC covers Q2 2026 (filed Jul 16, 2026): 112 long positions worth $211.1M. The top 10 holdings make up 70.1% of the portfolio, and the largest is Ea Series Trust at 19.2%. Livermore has 7 filings on Form 13F from this institution, going back to Q4 2024.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
18
Est. +$3.42M
Added
38
Est. +$17.0M
Reduced
39
Est. −$4.56M
Sold out
4
Est. −$1.31M

Top 5 holdings

Share of this quarter's portfolio value

  1. Ea Series Trust02072L532
    19.2%$40.5M
  2. iShares Tr464287150
    12.2%$25.7M
  3. American Centy ETF Tr025072802
    8.8%$18.7M
  4. Dimensional ETF Trust25434V732
    6.8%$14.4M
  5. Dimensional ETF Trust25434V831
    5.7%$12.1M

Share of portfolio

Top 5 holdings and the other 107 positions, by share of portfolio value

  1. Ea Series Trust19.2%
  2. iShares Tr12.2%
  3. American Centy ETF Tr8.8%
  4. Dimensional ETF Trust6.8%
  5. Dimensional ETF Trust5.7%
  6. Other 107 positions47.3%

Biggest buys

New and added positions, by estimated amount bought

  1. Ea Series Trust02072L532
    +$3.79MAdded
  2. iShares Tr464287150
    +$3.75MAdded
  3. American Centy ETF Tr025072802
    +$1.71MAdded
  4. Dimensional ETF Trust25434V831
    +$1.71MAdded
  5. Dimensional ETF Trust25434V765
    +$1.17MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. iShares Tr464287150
    +1.31 pp10.9% → 12.2%
  2. Ea Series Trust02072L532
    +0.63 pp18.6% → 19.2%
  3. Dimensional ETF Trust25434V831
    +0.49 pp5.2% → 5.7%
  4. TXG10x Genomics, Inc.
    +0.14 pp0.0% → 0.1%History
  5. STXSeagate Technology Holdings plc
    +0.13 pp0.0% → 0.1%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. INTCIntel Corp
    −$997.4KReducedHistory
  2. ANETArista Networks, Inc.
    −$677.9KReducedHistory
  3. GEGeneral Electric Co
    −$507.0KReducedHistory
  4. REGNRegeneron Pharmaceuticals, Inc.
    −$432.3KSold outHistory
  5. WDCWestern Digital Corp
    −$401.2KReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. REGNRegeneron Pharmaceuticals, Inc.
    −0.25 pp0.2% → 0.0%History
  2. NVDANVIDIA Corp
    −0.23 pp1.4% → 1.2%History
  3. GEGeneral Electric Co
    −0.22 pp0.4% → 0.2%History
  4. ANETArista Networks, Inc.
    −0.19 pp0.5% → 0.3%History
  5. PEPPepsiCo Inc
    −0.19 pp0.2% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$211.1M
+$36.6M (+21.0%) vs. prior quarter
Positions
112
+14 vs. prior quarter
Top 10 concentration
70.1%
Top 10 as share of value
Turnover
3.0%
Q2 2026, one quarter
Average holding period
6.6 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2024), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q4 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $211.1M (Q2 2026)

Q4 2024: $97.2MQ1 2025: $139.9MQ2 2025: $158.0MQ3 2025: $182.7MQ4 2025: $192.0MQ1 2026: $174.5MQ2 2026: $211.1M
Q4 2024Q2 2026
13F filings of Kaufman Rossin Wealth, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 16, 2026112$211.1MEa Series TrustiShares TrAmerican Centy ETF Trvs. Q1 2026SEC
Q1 2026Apr 17, 202698$174.5MEa Series TrustiShares TrAmerican Centy ETF Trvs. Q4 2025SEC
Q4 2025Jan 14, 2026157$192.0MEa Series TrustiShares TrAmerican Centy ETF Trvs. Q3 2025SEC
Q3 2025Oct 14, 2025155$182.7MEa Series TrustiShares TrAmerican Centy ETF Trvs. Q2 2025SEC
Q2 2025Jul 11, 2025139$158.0MEa Series TrustiShares TrAmerican Centy ETF Trvs. Q1 2025SEC
Q1 2025May 14, 2025150$139.9MEa Series TrustiShares TrAmerican Centy ETF Trvs. Q4 2024SEC
Q4 2024Jan 23, 202537$97.2MEa Series TrustiShares TrAmerican Centy ETF Tr–SEC